Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Microbot Medical Inc.NASDAQ: MBOT
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 93.1% from a year ago
Common stock stood at $672K at the end of Q1 FY2026, up 93.1% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +103.3% a year.
Context
- Common stock amounted to 0.9% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +93.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 672K USD
- Year-over-year change
- +244.6%
- 4-year CAGR
- +74.8%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 672K | +244.6% |
| FY2024 | 2024-12-31 | 195K | +65.3% |
| FY2023 | 2023-12-31 | 118K | +47.5% |
| FY2022 | 2022-12-31 | 80K | +11.1% |
| FY2021 | 2021-12-31 | 72K | — |
Common Stock vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +93.1% is the 3rd highest of 10, against a peer median of +3.4%.
- Common stock amounts to 0.9% of total assets for MBOT, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$213.35M CAD | +19.0% | +22.9% | 677.6% | |
| Mar 2026 | CA$92.54M CAD | +3.4% | +2.6% | 611.8% | |
| Mar 2026 | $12.01M USD | +1200500.0% | -47.7% | 55.4% | |
| Mar 2026 | $672K USD | +93.1% | +103.3% | 0.9% | |
| Mar 2026 | $491K USD | +0.0% | -0.3% | 0.2% | |
| Mar 2026 | $167K USD | +135.2% | +22.6% | 0.1% | |
| Mar 2026 | $91.88K USD | +2.4% | +79.2% | 0.2% | |
| Mar 2026 | $9.88K USD | -1.4% | -1.2% | 0.0% | |
| Mar 2026 | $8K USD | +33.3% | +17.0% | 0.0% | |
| Mar 2026 | -$632K USD | -21166.7% | — | 1.2% | |
| Peer median (excluding MBOT) | — | +3.4% | +9.8% | 0.2% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.